Exceedingly rich, white men (and women) who invest in biomedical companies are funding myriad transgender organisations whose agenda will make them gobs of money. We Object.
Exceedingly rich, white men (and women) who invest in biomedical companies are funding myriad transgender organisations whose agenda will make them gobs of money. We Object.
